SprintRay Introduces Intraoral Scanner, Chairside 3D Printing System and Restorative Resin - Scorecard - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

SprintRay Introduces Intraoral Scanner, Chairside 3D Printing System and Restorative Resin

  • By

  • News Staff

  • October 13, 2026

Share

Clinical Scorecard: SprintRay Introduces Intraoral Scanner, Chairside 3D Printing System and Restorative Resin

At a Glance

CategoryDetail
ConditionDigital dentistry product announcement covering intraoral scanning, chairside 3D printing, and restorative materials.
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • Foundation is a wireless, full-color intraoral scanner designed to operate with SprintRay ScanOS and its cloud dashboard.
  • Nano Series comprises NanoPrint, NanoWash, and NanoCure, with the three components occupying a combined footprint of less than 30 inches of counter space.
  • SprintRay reports that its analysis of more than 20 million dental parts produced through its ecosystem found that more than 80% of chairside print jobs involved a single patient and a single case.
  • GC GRADIA PREMi is a hybrid ceramic restorative resin developed with GC Corporation for the Midas Digital Press workflow.
  • Foundation and Nano Series shipments are expected to begin in November 2026 in specified markets; availability and indications are subject to regional requirements.

Guideline-Based Recommendations

Diagnosis

    Management

    • SprintRay says Foundation captures scans and makes resulting files available in the same interface used for design and production, without a separate export or upload step.
    • Nano Series includes AutoPrint and Job Handoff functions intended to connect production stages and transfer case information through the workflow.
    • SprintRay states that supported clinical applications depend on its validated materials library; indications and availability vary by market.

    Monitoring & Follow-up

    • Confirm regional product availability and regulatory requirements before use.
    • Consult GC’s final approved product labeling for GC GRADIA PREMi indications and performance information.

    Risks

    • The article does not report clinical safety outcomes or specific adverse effects.
    • Specific clinical indications, performance claims, and regional availability for GC GRADIA PREMi remain subject to final approved labeling and regulatory review.

    Patient & Prescribing Data

    No patient-level population or clinical trial data are reported.

    The article describes dental equipment and a restorative resin, not a treatment study. The companies state that GC GRADIA PREMi is intended to expand options for definitive chairside restorations using the Midas Digital Press platform; specific indications await final approved labeling.

    Clinical Best Practices

    • SprintRay states that supported clinical applications depend on its validated materials library; consult applicable regional labeling for indications.
    • Check market-specific availability and regulatory requirements; NanoWash will not be included in the Canadian Nano Series launch offering.
    • Refer to final approved GC labeling for GC GRADIA PREMi clinical indications and performance claims.

    Related Resources & Content

    Original Source(s)

    Related Content